|CHAPEL HILL, N.C., Oct 24, 2002 (BUSINESS WIRE) -- POZEN Inc. (NASDAQ:POZN), a
pharmaceutical development company with a portfolio of product candidates for
the treatment of migraine, today announced it will host a conference call
following the release of financial results for the second quarter ended
September 30, 2002. The company will release earnings before the market opens on
Thursday, October 31, 2002. John R. Plachetka, Pharm.D., POZEN's chairman,
president and chief executive officer, and Matthew E. Czajkowski, chief
financial officer, will host the conference call the same day at 11:00 a.m.
The conference call will be simulcast live on the Internet, and can be accessed
by logging on to www.pozen.com. A replay will be available for seven days in the
Investor Relations section of the company's website.
POZEN is a pharmaceutical development company committed to building a portfolio
of products with significant commercial potential in select therapeutic areas.
POZEN's initial focus is on developing products for migraine therapy, a global
market expected to exceed $2.8 billion this year. The company's common stock is
traded on The Nasdaq Stock Market under the symbol "POZN."
Chief Financial Officer
Director, Investor Relations